Calcutta HC orders week-long deadline on blood bank probe in West Bengal
Synopsis
Key Takeaways
The Calcutta High Court on Wednesday, 19 August directed the West Bengal Health Department to wrap up its ongoing investigation against 11 private blood banks within one week, after the banks were accused of severe irregularities — including the unauthorised sale of blood and plasma to other states. The directive came from a single-judge bench presided over by Justice Krishna Rao, who declined to stay the probe but imposed a firm completion deadline.
Background: What Triggered the Probe
The West Bengal Health Department launched the investigation following specific complaints that these 11 private blood banks had been collecting blood beyond permissible limits through donation camps and subsequently selling blood and plasma outside the state without authorisation. Multiple irregularities surfaced during the early stages of the inquiry, prompting authorities to impose a ban on the banks from organising blood donation camps anywhere in West Bengal until further orders.
Court Proceedings
One of the 11 blood banks challenged the Health Department's ban before the Calcutta High Court, bringing the matter to a hearing on Wednesday. Justice Krishna Rao's bench chose not to interfere with the investigation itself but set a one-week timeline for the department to conclude its findings. The court's intervention effectively places the probe under judicial oversight without disrupting its progress.
Partial Relief and Ongoing Scrutiny
Earlier, following discussions and on practical grounds, the blanket ban on blood collection by these banks was partially lifted, giving the concerned institutions time to rectify past irregularities. However, the Health Department opted to press ahead with the full investigation regardless. The restrictions remain in place under guidelines issued by the Blood Transfusion Council of the Health Department.
What Happens Next
The West Bengal Health Department is now required to complete its probe and submit findings within the court-mandated one-week window. Depending on the outcome, the 11 private blood banks could face further regulatory action, including potential licence cancellations or extended bans. The case highlights growing scrutiny over the regulation of private blood banks and the cross-state movement of blood products across India.